Detalhe da pesquisa
1.
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization.
Eur Radiol
; 32(9): 5799-5810, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381853
2.
Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling.
Mol Cancer
; 20(1): 46, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658044
3.
Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
Am J Gastroenterol
; 116(7): 1447-1464, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33630766
4.
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.
Invest New Drugs
; 38(5): 1247-1256, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31832851
5.
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study.
J Hepatol
; 70(5): 893-903, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30660709
6.
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC.
Invest New Drugs
; 37(3): 401-414, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30019101
7.
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.
BMC Cancer
; 19(1): 409, 2019 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31039750
8.
Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
J Vasc Interv Radiol
; 30(2): 148-153.e2, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30638778
9.
Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
BMC Gastroenterol
; 18(1): 138, 2018 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30180810
10.
mRECIST response combined with sorafenib-related adverse events is superior to either criterion alone in predicting survival in HCC patients treated with TACE plus sorafenib.
Int J Cancer
; 140(2): 390-399, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27681592
11.
Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
J Hepatol
; 67(3): 508-516, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28506905
12.
Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
Am J Gastroenterol
; 117(1): 200, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882097
13.
Chemoembolization for Hepatocellular Carcinoma in Patients with Extrahepatic Spread: Prognostic Determinants and Appropriate Candidates.
J Vasc Interv Radiol
; 28(7): 956-962, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28420555
14.
Reply to: "The "six-and-twelve score" for TACE treatment: Does it really help us?"
J Hepatol
; 71(5): 1053-1054, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500855
15.
Potential candidates for liver resection in liver-confined advanced HCC: a Chinese multicenter observational study.
Front Oncol
; 13: 1170923, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434986
16.
Clinical course and outcomes of COVID-19 patients with chronic obstructive pulmonary disease: A retrospective observational study in Wuhan, China.
Medicine (Baltimore)
; 101(18): e29141, 2022 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550462
17.
Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.
JHEP Rep
; 4(5): 100448, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313729
18.
Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study.
Front Oncol
; 12: 983554, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36776366
19.
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study.
Liver Cancer
; 11(4): 368-382, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35978600
20.
Implications of Laboratory Tests in Disease Grading and Death Risk Stratification of COVID-19: A Retrospective Study in Wuhan, China.
Front Med (Lausanne)
; 8: 629296, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693017